V. Dalay

Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases

I. Langley, B. Squire, D. Marcelo, 2019, PLoS ONE.

Patient-cost survey for tuberculosis in the context of patient-pathway modelling.

I. Langley, S. Squire, D. Marcelo, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of GeneXpert and the role of an expert panel in improving clinical diagnosis of smear-negative tuberculosis cases.

I. Langley, B. Squire, D. Marcelo, 2019, PloS one.

Treatment Strategy for Rifampin-Susceptible Tuberculosis.

A. Crook, A. Nunn, N. Paton, 2023, The New England journal of medicine.

ARE THREE SPUTUM SPECIMENS NECESSARY TO DIAGNOSIS PULMONARY TUBERCULOSIS

A. Sarkin, T. Ganiats, A. Catanzaro, 2006 .

Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.

C. Kityo, N. Paton, K. Chew, 2023, The Lancet. Infectious diseases.